Rho kinase proteins regulate global miRNA expression in endothelial cells

Cancer Genomics and Proteomics

Volumn 10, Issue 6, 2013, Pages 251-264

  Stiles, Jessica M ^a   Kurisetty, Vittal ^a   Mitchell, Dianne C ^a   Bryan, Brad A ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

Author keywords

Angiogenesis; Endothelial cell; Microarrays; miRNA; Rho kinase; ROCK; shRNA; Tumor vasculature

Indexed keywords

MICRORNA; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE 1; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE 2; RHO KINASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL CYCLE PROGRESSION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; MICROARRAY ANALYSIS; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; SIGNAL TRANSDUCTION; STEADY STATE; SYNAPTOGENESIS;

ANGIOGENESIS; ENDOTHELIAL CELL; MICROARRAYS; MIRNA; RHO KINASE; ROCK; SHRNA; TUMOR VASCULATURE;

ANIMALS; CELL LINE; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; MICE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RHO-ASSOCIATED KINASES; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84890861552     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Street CA and Bryan BA: Rho kinase proteins - pleiotropic modulators of cell survival and apoptosis. Anticancer Res 31: 3645-3657, 2001.
2. Rath N and Olson MF: Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy. EMBO Rep 13: 900-908, 2012.
3. Bryan BA, Dennstedt E, Mitchell DC, Walshe TE, Noma K, Loureiro R, Saint-Geniez M, Campaigniac JP, Liao JK and D'Amore PA: RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J 24: 3186-3195, 2010.
4. Montalvo J, Spencer C, Hackathorn A, Masterjohn K, Perkins A, Doty C, Arumugam A, Ongusaha PP, Lakshmanaswamy R, Liao JK, Mitchell DC and Bryan BA: ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression. Curr Mol Med 13 : 205-219, 2013.
5. Bryan BA and D'Amore PA: What tangled webs they weave: Rho-GTPase control of angiogenesis. Cell Mol Life Sci 64: 2053-2065, 2007.
6. Mavria G, Vercoulen Y, Yeo M, Paterson H, Karasarides M, Marais R, Bird D and Marshall CJ: ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell 9: 33-44, 2006.
7. Yin L, Morishige K, Takahashi T, Hashimoto K, Ogata S, Tsutsumi S, Takata K, Ohta T, Kawagoe J, Takahashi K and Kurachi H: Fasudil inhibits vascular endothelial growth factorinduced angiogenesis in vitro and in vivo. Mol Cancer Ther 6: 1517-1525, 2007.
8. Hata Y, Miura M, Nakao S, Kawahara S, Kita T and Ishibashi T: Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor. Jpn J Ophthalmol 52: 16-23, 2008.
9. Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M and Ingber DE: Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci USA 105 : 11305-11310, 2008.
10. Mammoto A, Mammoto T and Ingber DE: Mechanosensitive mechanisms in transcriptional regulation. J Cell Sci 125: 3061-3073, 2012.
11. Spencer C, Montalvo J, McLaughlin SR and Bryan BA: Small molecule inhibition of cytoskeletal dynamics in melanoma tumors results in altered transcriptional expression patterns of key genes involved in tumor initiation and progression. Cancer Genomics Proteomics 8: 77-85, 2011.
12. Berenjeno IM and Bustelo XR: Identification of the Rockdependent transcriptome in rodent fibroblasts. Clin Transl Oncol 10: 726-738, 2008.
13. Boerma M, Fu Q, Wang J, Loose DS, Bartolozzi A, Ellis JL, McGonigle S, Paradise E, Sweetnam P, Fink LM, Vozenin-Brotons MC and Hauer-Jensen M: Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin. Blood Coagul Fibrinolysis 19 : 709-718, 2008.
14. Harvey SA, Anderson SC and SundarRaj N: Downstream effects of ROCK signaling in cultured human corneal stromal cells: microarray analysis of gene expression. Invest Ophthalmol Vis Sci 45: 2168-2176, 2004.
15. Liu S, Goldstein RH, Scepansky EM and Rosenblatt M: Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res 69: 8742-8751, 2009.
16. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M and Narumiya S: Pharmacological properties of Y- 27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57 : 976-983, 2000.
17. Pirooznia M, Nagarajan V and Deng Y: GeneVenn - A web application for comparing gene lists using Venn diagrams. Bioinformation 1: 420-422, 2007.
18. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
19. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S, Byers HR and Folkman J: Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA 94: 861-866, 1997.
20. McCall MN, Kent OA, Yu J, Fox-Talbot K, Zaiman AL and Halushka MK: MicroRNA profiling of diverse endothelial cell types. BMC Med Genomics 4 : 78, 2011.
21. Nishioka T, Nakayama M, Amano M and Kaibuchi K: Proteomic screening for Rho-kinase substrates by combining kinase and phosphatase inhibitors with 14-3-3zeta affinity chromatography. Cell Struct Funct 37: 39-48, 2012.
22. Jain N, Iyer KV, Kumar A and Shivashankar GV: Cell geometric constraints induce modular gene-expression patterns via redistribution of HDAC3 regulated by actomyosin contractility. Proc Natl Acad Sci USA 110: 11349-11354, 2013.
23. Stiles JM, Pham R, Rowntree RK, Amaya C, Battiste J, Boucheron LE, Mitchell DC and Bryan BA: Morphological restriction of human coronary artery endothelial cells substantially impacts global gene expression patterns. FEBS J 280: 4474-4494, 2013.
24. Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE, Shi F and Zhou X: Down-regulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 127 : 505-512, 2010.
25. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT, Man K and Ng IO: The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 140 : 322-331, 2011.
26. Ueno K, Hirata H, Shahryari V, Chen Y, Zaman MS, Singh K, Tabatabai ZL, Hinoda Y and Dahiya R: Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer 104: 308-315, 2011.
27. Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, Liu L, Jia D, Tian Q, Wu J, Ye Y, Wang Q, Long Z, Zhou Y, Du C, He X and Shi Y: MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 17: 7574-7583, 2011.
28. Cimino D, De Pitta C, Orso F, Zampini M, Casara S, Penna E, Quaglino E, Forni M, Damasco C, Pinatel E, Ponzone R, Romualdi C, Brisken C, De Bortoli M, Biglia N, Provero P, Lanfranchi G and Taverna D: miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. FASEB J 27 : 1223-1235, 2013.
29. Amano M, Nakayama M and Kaibuchi K: Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken) 67: 545-554, 2010.
30. Huppi K, Pitt J, Wahlberg B and Caplen NJ: Genomic instability and mouse microRNAs. Toxicol Mech Methods 21 : 325-333, 2011.
31. Sterling KM: The procollagen type III, alpha 1 (COL3A1) gene first intron expresses poly-A+ RNA corresponding to multiple ESTs and putative miRNAs. J Cell Biochem 112: 541-547, 2011.
32. Chen YQ, Wang XX, Yao XM, Zhang DL, Yang XF, Tian SF and Wang NS: Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice. J Nephrol 25: 566-576, 2012.
33. Ding Y, Tian M, Liu J, Deng Y, Li W, Feng X and Hou D: Expression profile of miRNAs in APP swe/PSDeltaE9 transgenic mice. Nan Fang Yi Ke Da Xue Xue Bao 32: 1280-1283, 2012.
34. Samarin SN, Ivanov AI, Flatau G, Parkos CA and Nusrat A: Rho/Rho-associated kinase-II signaling mediates disassembly of epithelial apical junctions. Mol Biol Cell 18: 3429-3439, 2007.
35. Thongon N, Nakkrasae LI, Thongbunchoo J, Krishnamra N and Charoenphandhu N: Prolactin stimulates transepithelial calcium transport and modulates paracellular permselectivity in Caco-2 monolayer: mediation by PKC and ROCK pathways. Am J Physiol Cell Physiol 294 : C1158-1168, 2008.
36. Cazzola M, Calzetta L, Rogliani P, Lauro D, Novelli L, Page CP, Kanabar V and Matera MG: High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. Am J Respir Cell Mol Biol 47 : 509-516, 2012.
37. 2+ release, and RhoA/ROCK activation. Eur J Pharmacol 697 : 88-96, 2012.
38. Martinsen A, Yerna X, Rath G, Gomez EL, Dessy C and Morel N: Different effect of Rho kinase inhibition on calcium signaling in rat isolated large and small arteries. J Vasc Res 49 : 522-533, 2012.
39. Kubo T and Yamashita T: Rho-ROCK inhibitors for the treatment of CNS injury. Recent Pat CNS Drug Discov 2: 173-179, 2007.
40. Mueller BK, Mack H and Teusch N: Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 4: 387-398, 2005.